Impact of Percutaneous Device Implantation for Closure of Patent Foramen Ovale on Valve Insufficiencies | Zendy

Jochen Wöhrle | Zendy; Matthias Kochs | Zendy; Jochen Spieß | Zendy; Thorsten Nusser | Zendy; Vinzenz Hombach | Zendy; Nico Merkle | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Percutaneous Device Implantation for Closure of Patent Foramen Ovale on Valve Insufficiencies

Author(s) -

Jochen Wöhrle,

Matthias Kochs,

Jochen Spieß,

Thorsten Nusser,

Vinzenz Hombach,

Nico Merkle

Publication year - 2009

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.851014

Subject(s) - medicine , patent foramen ovale , percutaneous , closure (psychology) , foramen ovale (heart) , cardiology , surgery , economics , market economy

In patients with percutaneous device implantation for closure of patent foramen ovale (PFO), a 10% incidence of new or worsened aortic regurgitation within 12 months has been reported with echocardiography. Cardiac magnetic resonance imaging is a powerful noninvasive tool to quantify volume and fraction of valve insufficiencies. We studied the acute and long-term impact of percutaneous device implantation for PFO closure on valve insufficiencies in cardiac magnetic resonance imaging.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research